Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva UK has rolled out Levetiracetam film-coated tablets as a monotherapy to treat partial onset seizures with or without second generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Subscribe to our email newsletter
Teva’s Levetiracetam tablets are the generic version of UCB Pharma’s Keppra (levetiracetam).
The drug is available in 250, 500, 750 and 1,000mg film-coated tablets in the market.
Levetiracetam tablets are also used as an adjunctive therapy to treat onset seizures with or without secondary generalisation in adults, children and infants from 1 month of age with epilepsy.
The product as an adjunctive therapy, is also used in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy and to treat primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.